UHN
Inventor(s) |
Technology Description |
Publication
Link |
One Page
Overview |
| L. Zhang; K, Young, M. Han |
Novel T-Cell Immunotherapy |
Link |
Link |
| J. Dick; E. Lechman; K. Hope |
MicroRNA-126 for Enhancing Stem Cell Engraftment and Monitoring the Treatment of Acute Myeloid Leukemia |
Link |
Link |
| E. Ito; F-F. Liu |
Enhancing Sensitivity to Radiotherapy and Chemotherapy of Head and Neck Cancer |
Link |
Link |
| A. Schimmer; et al |
Clioquinol Analogues for Treatment of Lymphoid Malignancies |
Link |
Link |
| A. Schimmer |
Combination Therapy using a Clioquinol Analogue and Bortezomib (Velcade) for Treatment of Lymphoid Malignancies |
Link |
Link |
| A. Schimmer; Y. Eberhard |
Ciclopirox Olamine in Combination with Cytarabine for Treatment of Lymphoid Malignancies |
Link |
Link |
| J. Medin; C. Paige |
IL-12 Immunotherapy for the Treatment of Cancer |
Link |
Link |
| J. Medin; Andrea McCart |
Immunotherapy for Cancer via Lentiviral Mediated
Cancer Antigen Administration |
Link |
Link |
| A. Schimmer; et al |
Ivermectin in Combination with Cytarabine and/or Daunorubicin for Treatment of Lymphoid Malignancies |
Link |
Link |
| L. Kotra; A.Bello; E. Pai; C. Paige |
ODCase Inhibitors as Novel Anti-Cancer Agents |
Link |
Link |
| A. Schimmer; et al |
Flubendazole in Combination with Vinca Alkaloids for the Treatment of Leukemia |
Link |
Link |
| J. Dick; et al |
Leukemia and Hematopoietic Stem Cell Signatures
for Predicting Survival of Patients Having Acute Myeloid Leukemia |
Link |
Link |
| L. Penn; A. Schimmer; A. Pandyra |
Treating Cancer with Statins and Dipyridamole |
Link |
Link |
| M. Fehlings; S. Robins |
The Therapeutic Use of IgG as a Neuroprotective Agent |
Link |
Link |
| M. Erwin; R. Inman; M. Fehlings |
Notochordal Cells for Treatment of Degenerative Disk Diseases |
Link |
Link |
| S. Berger |
Novel Method for Increasing Antibody Production |
Link |
Link |
| I. Crandall; W. Szarek |
Novel Antibiotic Agents |
Link |
Link |
| E.Fish; L.Kotra |
Peptide Mimetics for Treatment of Autoimmune and Viral Diseases |
Link |
Link |
| L. Kotra; K. Kain; E. Pai |
ODCase Inhibitors as Novel Anti-Malarial Drugs |
Link |
Link |
| K. Kain; L. Serghides |
Treatment for Severe and Cerebral Malaria |
Link |
Link |
| I.Crandall; K. Kain; R. Reithmeier; J. Charuk |
Malaria Drug Resistance Reversal Agent |
Link |
Link |
| I. Crandall; W. Szarek |
Small Molecule Malaria Invasion Inhibitors |
Link |
Link |
